Latest stories on REVB
Revelation Biosciences Inc trading halted, news pending
The Fly50 · neutralgeneral
Revelation Biosciences announces 1-for-7 reverse stock split
The Fly31 · bearishgeneral
Revelation Biosciences Announces 1-for-7 Reverse Stock Split Effective October 20, 2026
StockTitan31 · bearishgeneral
OpenAI's latest AI revelation is a 'serious situation,' Microsoft's Suleyman tells CNBC
CNBC38 · neutralgeneral
REVELATION BIOSCIENCES, INC. (REVBW) files 8-K
SEC 8-K50 · neutralgeneral
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study
StockTitan56 · neutralproduct/pr
Revelation Biosciences GAAP EPS of -$0.87
Seeking Alpha34 · bearishearnings
REVELATION BIOSCIENCES, INC. (REVBW) files 8-K
SEC 8-K50 · neutralgeneral
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026
StockTitan50 · neutralgeneral
Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
Revelation Biosciences Adopts Stockholder Rights Protection Plan
TipRanks42 · neutralgeneral
REVELATION BIOSCIENCES, INC. (REVBW) files 8-K
SEC 8-K50 · neutralgeneral
Revelation Biosciences Announces Adoption of Stockholder Rights Plan | REVB Stock News
StockTitan48 · neutralgeneral
REVELATION BIOSCIENCES, INC. (REVBW) files 8-K
SEC 8-K50 · neutralgeneral
Revelation Biosciences Expands Acute Kidney Injury Advisory Board | REVB Stock News
StockTitan56 · neutralproduct/pr
Healthcare Secondaries Manager Revelation Partners Appoints Prashant Gangwal as Partner and CFO
PR Newswire59 · neutralgeneral